Active specific immunotherapy with therapeutic melanoma vaccines
Record ID 32010001380
English
Authors' recommendations:
Active specific immunotherapy with therapeutic melanoma vaccines is designed to elicit an immune response by recruiting specific effector cells to produce antibodies or a T-cell response directed against one or more specific tumor antigens. The goals of treatment with melanoma vaccines include tumor regression, prolongation of disease-free and overall survival, and improved quality of life.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=1811
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Immunotherapy, Active
- Melanoma
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.